Lysophosphatidic acid (LPA)-induced vascular endothelial growth factor (VEGF) by mesothelial cells and quantification of host-derived VEGF in malignant ascites

Journal of Surgical Research

Volumn 130, Issue 1, 2006, Pages 94-101

  Sako, Akihiro ^a,c   Kitayama, Joji ^a   Shida, Dai ^a   Suzuki, Rika ^b   Sakai, Teruyuki ^b   Ohta, Hideo ^b   Nagawa, Hirokazu ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b KIRIN BREWERY CO LTD   (Japan)

^c THE UNIVERSITY OF TOKYO   (Japan)

Author keywords

Ascites; Host derived; LPA; Mesothelial cell; VEGF

Indexed keywords

LYSOPHOSPHATIDIC ACID; PERTUSSIS TOXIN; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASCITES FLUID; ASCITES TUMOR; BIOLOGY; CANCER CELL; CONCENTRATION (PARAMETERS); ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE ACTIVATION; HOST CELL; HUMAN; HUMAN CELL; INOCULATION; MESOTHELIUM CELL; MOUSE; NONHUMAN; NORTHERN BLOTTING; NUDE MOUSE; PERITONEAL CAVITY; PERITONEUM CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STIMULATION; STOMACH CANCER; TUMOR GROWTH;

ANIMALS; ASCITES; CELL LINE, TUMOR; CULTURE MEDIA, CONDITIONED; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; EPITHELIUM; FEMALE; HUMANS; ISOXAZOLES; LYSOPHOSPHOLIPIDS; MICE; MICE, INBRED BALB C; MICE, NUDE; PERTUSSIS TOXIN; PROPIONIC ACIDS; RECEPTORS, LYSOPHOSPHATIDIC ACID; RNA, MESSENGER; STOMACH NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 29744434743     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2005.08.007     Document Type: Article

References (57)

1. J. Folkman Tumor angiogenesis Therapeutic implications N. Engl. J. Med. 285 1971 1182
2. N. Ferrara, H.P. Gerber, J. LeCouter The biology of VEGF and its receptors Nat. Med. 9 2003 669
3. A. Mori, S. Arii, M. Furutani Soluble Flt-1 gene therapy for peritoneal metastases using HVJ-cationic liposomes Gene Ther. 7 2000 1027
4. N. Akutagawa, A. Nishikawa, M. Iwasaki Expression of vascular endothelial growth factor and e-cadherin in human ovarian cancer Association with ascites fluid accumulation and peritoneal dissemination in mouse ascites model Jpn. J. Cancer Res. 93 2002 644
5. H. Yabushita, M. Shimazu, M. Noguchi, T. Kishida, H. Narumiya, K. Sawaguchi Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer Oncol. Rep. 10 2003 89
6. R.M. Shaheen, S.A. Ahmad, W. Liu Inhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptors Br. J. Cancer 85 2001 584
7. T. Tanaka, H. Konno, S. Baba Prevention of hepatic and peritoneal metastases by the angiogenesis inhibitor fr-118487 after removal of growing tumor in mice Jpn. J. Cancer Res. 92 2001 88
8. A. Kraft, K. Weindel, A. Ochs Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease Cancer 85 1999 178
9. B.K. Zebrowski, W. Liu, K. Ramirez, Y. Akagi, G.B. Mills, L.M. Ellis Markedly elevated levels of vascular endothelial growth factor in malignant ascites Ann. Surg. Oncol. 6 1999 373
10. M. Shibuya, J.C. Luo, M. Toyoda, S. Yamaguchi Involvement of VEGF and its receptors in ascites tumor formation Cancer Chemother. Pharmacol. 43 Suppl 1999 S72
11. W.G. Dong, X.M. Sun, B.P. Yu, H.S. Luo, J.P. Yu Role of VEGF and CD44v6 in differentiating benign from malignant ascites World J. Gastroenterol. 9 2003 2596
12. J.H. Harmey, E. Dimitriadis, E. Kay, H.P. Redmond, D. Bouchier-Hayes Regulation of macrophage production of vascular endothelial growth factor (VEGF) by hypoxia and transforming growth factor beta-1 Ann. Surg. Oncol. 5 1998 271
13. G. Lummen, S. Blass-Kampmann, H. Rubben, J. Suhr, T. Otto Tumor-infiltrating lymphocytes express vascular endothelial growth factor in renal cell carcinomas Onkologie 23 2000 458
14. J.P. Shaw, N. Chuang, H. Yee, P. Shamamian Polymorphonuclear neutrophils promote rFGF-2-induced angiogenesis in vivo J. Surg. Res. 109 2003 37
15. Y. Takahashi, C.D. Bucana, W. Liu Platelet-derived endothelial cell growth factor in human colon cancer angiogenesis Role of infiltrating cells J. Natl. Cancer Inst. 88 1996 1146
16. C.S. Williams, M. Tsujii, J. Reese, S.K. Dey, R.N. DuBois Host cyclooxygenase-2 modulates carcinoma growth J. Clin. Invest. 105 2000 1589
17. D.G. Jayne, S.L. Perry, E. Morrison, S.M. Farmery, P.J. Guillou Activated mesothelial cells produce heparin-binding growth factors Implications for tumour metastases Br. J. Cancer 82 2000 1233
18. A. Sako, J. Kitayama, H. Yamaguchi Vascular endothelial growth factor synthesis by human omental mesothelial cells is augmented by fibroblast growth factor-2 Possible role of mesothelial cell on the development of peritoneal metastasis J. Surg. Res. 115 2003 113
19. S.E. Mutsaers, R.J. McAnulty, G.J. Laurent, M.A. Versnel, D. Whitaker, J.M. Papadimitriou Cytokine regulation of mesothelial cell proliferation in vitro and in vivo Eur. J. Cell Biol. 72 1997 24
20. N. Jonjic, G. Peri, S. Bernasconi Expression of adhesion molecules and chemotactic cytokines in cultured human mesothelial cells J. Exp. Med. 176 1992 1165
21. L. Lanfrancone, D. Boraschi, P. Ghiara Human peritoneal mesothelial cells produce many cytokines (granulocyte colony-stimulating factor [CSF], granulocyte-monocyte-CSF, macrophage-CSF, interleukin-1 [IL-1], and IL-6) and are activated and stimulated to grow by IL-1 Blood 80 1992 2835
22. N. Topley, Z. Brown, A. Jorres Human peritoneal mesothelial cells synthesize interleukin-8. Synergistic induction by interleukin-1 beta and tumor necrosis factor-alpha Am. J. Pathol. 142 1993 1876
23. N. Topley, A. Jorres, W. Luttmann Human peritoneal mesothelial cells synthesize interleukin-6 Induction by IL-1 beta and TNF alpha Kidney Int. 43 1993 226
24. N. Topley The cytokine network controlling peritoneal inflammation Perit. Dial. Int. 15 1995 S35
25. W.H. Moolenaar Development of our current understanding of bioactive lysophospholipids Ann. NY Acad. Sci. 905 2000 1
26. S. An, T. Bleu, O.G. Hallmark, E.J. Goetzl Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid J. Biol. Chem. 273 1998 7906
27. K. Bandoh, J. Aoki, H. Hosono Molecular cloning and characterization of a novel human G-protein- coupled receptor, EDG7, for lysophosphatidic acid J. Biol. Chem. 274 1999 27776
28. M. Mukai, F. Imamura, M. Ayaki Inhibition of tumor invasion and metastasis by a novel lysophosphatidic acid (cyclic LPA) Int. J. Cancer 81 1999 918
29. D. Shida, J. Kitayama, H. Yamaguchi Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1 Cancer Res. 63 2003 1706
30. S. Sengupta, Y.J. Xiao, Y. Xu A novel laminin-induced LPA autocrine loop in the migration of ovarian cancer cells FASEB J. 17 2003 1570
31. T. Yamada, K. Sato, M. Komachi Lysophosphatidic acid (LPA) in malignant ascites stimulates motility of human pancreatic cancer cells through LPA1 J. Biol. Chem. 279 2004 6595
32. D.A. Fishman, Y. Liu, S.M. Ellerbroek, M.S. Stack Lysophosphatidic acid promotes matrix metalloproteinase (MMP) activation and MMP-dependent invasion in ovarian cancer cells Cancer Res. 61 2001 3194
33. D.L. Baker, D.M. Desiderio, D.D. Miller, B. Tolley, G.J. Tigyi Direct quantitative analysis of lysophosphatidic acid molecular species by stable isotope dilution electrospray ionization liquid chromatography-mass spectrometry Anal. Biochem. 292 2001 287
34. D.L. Baker, E.S. Umstot, D.M. Desiderio, G.J. Tigyi Quantitative analysis of lysophosphatidic acid in human blood fractions Ann. NY Acad. Sci. 905 2000 267
35. T. Sugiura, S. Nakane, S. Kishimoto, K. Waku, Y. Yoshioka, A. Tokumura Lysophosphatidic acid, a growth factor-like lipid, in the saliva J. Lipid Res. 43 2002 2049
36. Y.J. Xiao, B. Schwartz, M. Washington Electrospray ionization mass spectrometry analysis of lysophospholipids in human ascitic fluids Comparison of the lysophospholipid contents in malignant vs nonmalignant ascitic fluids Anal. Biochem. 290 2001 302
37. A.M. Westermann, E. Havik, F.R. Postma Malignant effusions contain lysophosphatidic acid (LPA)-like activity Ann. Oncol. 9 1998 437
38. Y. Xu, D.C. Gaudette, J.D. Boynton Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients Clin. Cancer Res. 1 1995 1223
39. H. Lee, E.J. Goetzl, S. An Lysophosphatidic acid and sphingosine 1-phosphate stimulate endothelial cell wound healing Am. J. Physiol. Cell Physiol. 278 2000 C612
40. T. Mio, X. Liu, M.L. Toews, S.I. Rennard Lysophosphatidic acid augments fibroblast-mediated contraction of released collagen gels J. Lab. Clin. Med. 139 2002 20
41. H. Ohta, K. Sato, N. Murata Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors Mol. Pharmacol. 64 2003 994
42. P. Chomczynski, N. Sacchi Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction Anal. Biochem. 162 1987 156
43. B. Berse, L.F. Brown, L. Van de Water, H.F. Dvorak, D.R. Senger Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors Mol. Biol. Cell. 3 1992 211
44. M.A. Goldberg, T.J. Schneider Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin J. Biol. Chem. 269 1994 4355
45. S.J. Cook, N. Aziz, M. McMahon The repertoire of fos and jun proteins expressed during the G1 phase of the cell cycle is determined by the duration of mitogen-activated protein kinase activation Mol. Cell. Biol. 19 1999 330
46. X. Fang, S. Yu, R.C. Bast Mechanisms for lysophosphatidic acid-induced cytokine production in ovarian cancer cells J. Biol. Chem. 279 2004 9653
47. A. Hahn, H. Barth, M. Kress, P.R. Mertens, M. Goppelt-Struebe Role of Rac and Cdc42 in lysophosphatidic acid-mediated cyclo-oxygenase-2 gene expression Biochem. J. 362 2002 33
48. Y.L. Hu, M.K. Tee, E.J. Goetzl Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells J. Natl. Cancer Inst. 93 2001 762
49. K. Noguchi, S. Ishii, T. Shimizu Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family J. Biol. Chem. 278 2003 25600
50. B.M. Schwartz, G. Hong, B.H. Morrison Lysophospholipids increase interleukin-8 expression in ovarian cancer cells Gynecol. Oncol. 81 2001 291
51. M.G. Betjes, C.W. Tuk, D.G. Struijk Interleukin-8 production by human peritoneal mesothelial cells in response to tumor necrosis factor-alpha, interleukin-1, and medium conditioned by macrophages cocultured with Staphylococcus epidermidis J. Infect. Dis. 168 1993 1202
52. P. Cejudo-Martin, M. Morales-Ruiz, J. Ros Hypoxia is an inducer of vasodilator agents in peritoneal macrophages of cirrhotic patients Hepatology 36 2002 1172
53. J. McLaren, A. Prentice, D.S. Charnock-Jones Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids J. Clin. Invest. 98 1996 482
54. S.W. Nam, T. Clair, C.K. Campo, H.Y. Lee, L.A. Liotta, M.L. Stracke Autotaxin (ATX), a potent tumor motogen, augments invasive and metastatic potential of ras-transformed cells Oncogene 19 2000 241
55. Y. Yang, L. Mou, N. Liu, M.S. Tsao Autotaxin expression in non-small-cell lung cancer Am. J. Respir. Cell. Mol. Biol. 21 1999 216
56. M. Umezu-Goto, Y. Kishi, A. Taira Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production J. Cell. Biol. 158 2002 227
57. J.L. Tanyi, Y. Hasegawa, R. Lapushin Role of decreased levels of lipid phosphate phosphatase-1 in accumulation of lysophosphatidic acid in ovarian cancer Clin. Cancer Res. 9 2003 3534